Cardiology

Resource Center

Featured

Research Summary
Research Summary
04/21/2026
Kate Young
In a post hoc analysis of the SURPASS-CVOT randomized clinical trial, researchers found that tirzepatide was associated with fewer cardiorenal events than dulaglutide in high-risk type 2 diabetes.
04/21/2026
Photoclinic Challenge
Photoclinic Challenge
04/18/2026
Anthony Calabro, MA
A 29-year-old woman with systemic lupus erythematosus and a history of hypertension presented to the emergency department with acute chest pain and lower extremity paresthesia.
04/18/2026
Research Summary
Research Summary
04/17/2026
Kate Young
In SOUL, oral semaglutide was associated with fewer composite heart failure events in patients with type 2 diabetes and baseline heart failure.
04/17/2026

Interactive Features

Photoclinic Challenge
Photoclinic Challenge
04/18/2026
Anthony Calabro, MA
A 29-year-old woman with systemic lupus erythematosus and a history of hypertension presented to the emergency department with acute chest pain and lower extremity paresthesia.
04/18/2026
Pop Quiz
Pop Quiz
04/08/2026
Ashton L. Stahl
Think metabolic syndrome trends have worsened across the board over the past decade? Test your knowledge of recent national findings and see which patient population is driving change.
04/08/2026
Pop Quiz
Pop Quiz
04/06/2026
Anthony Calabro, MA
Test your knowledge of the four interrelated conditions driving cardiometabolic risk and how early intervention can alter disease progression.
04/06/2026
Pop Quiz
Pop Quiz
03/26/2026
Kate Young
Diabetes mellitus represents one of the most powerful and prevalent cardiometabolic risk factors facing U.S. adults today. Test your knowledge about diabetes prevalence.
03/26/2026
Pop Quiz
Pop Quiz
03/10/2026
Kate Young
The 2026 Cardiovascular Statistics report provides a comprehensive review of trends in major cardiovascular risk factors—including hypertension, diabetes, obesity, dyslipidemia, and smoking—as well as the 5...
03/10/2026

Clinical Insights

Expert Q&A
Expert Q&A
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Nutrition411: The Podcast, Ep. 56
Nutrition411: The Podcast, Ep. 56
02/25/2026
Lisa Jones, MA, RDN, LDN, FAND; Grace A. Derocha, MBA, RD, CDCES
In the final episode of this four-part series, Lisa Jones, MA, RDN, LDN, FAND, and Grace A. Derocha, MBA, RD, CDCES, registered dietitian and a certified diabetes care and education specialist, discuss...
02/25/2026
Nutrition411: The Podcast, Ep. 55
Nutrition411: The Podcast, Ep. 55
02/18/2026
Lisa Jones, MA, RDN, LDN, FAND; Grace A. Derocha, MBA, RD, CDCES
In part four of this four-part series, Lisa Jones, MA, RDN, LDN, FAND, and Grace A. Derocha, MBA, RD, CDCES, registered dietitian and a certified diabetes care and education specialist, discuss structural...
02/18/2026
NUTRITION411: THE PODCAST, EP. 54
NUTRITION411: THE PODCAST, EP. 54
02/11/2026
Lisa Jones, MA, RDN, LDN, FAND; Grace A. Derocha, MBA, RD, CDCES
In part two of this four-part series, Lisa Jones, MA, RDN, LDN, FAND, and Grace A. Derocha, MBA, RD, CDCES, registered dietitian and a certified diabetes care and education specialist, discuss how...
02/11/2026
Expert Q&A
Expert Q&A
02/05/2026
Brian A. Bergmark, MD
In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...
02/05/2026